Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acadia, Aeglea, Alnylam, Arena, Argenx, Atara, Clene, Dermavant, Durect, Glenmark, GSK, Immunocore, Innovent, Janssen, Lilly, Mesoblast, Novavax, Oncolytics, Regeneron, Sanofi, Synairgen, Teva.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Boehringer, Daiichi, Geron, Incuron, Incyte, Leo, Navidea, Nektar, Oncopeptides, Retinset, Roche, Samumed, Syndax, Xeris.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Delft, Shuwen, Thirona.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Antisense, Apollomics, Arvelle, Entera Bio, Galapagos, Gilead, Kadmon, Poseida, Tonix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Beyond Air, Livanova, Sera Prognostics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alkermes, Arch, Astex, Beyond Air, Cidara, Cyclo, Diffusion, Forma, KBP, Roche, Santhera.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Abivax, Astellas, Bone, Glenmark, I-Mab, JHL, Kaleido, Moderna, Neurorx, Oryzon Genomics, Relief, Roivant Sciences, Samsung Bioepis, Taiwan Liposome, Zai Lab.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abiomed, Axonics, Castle Biosciences, Cerapedics, Eyenuk, Limflow, Medasense.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agios, Amplyx, Arbutus, Biogen, Covis, Hepion, Lidds, Mezzion, MGB Biopharma.